Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-031505
Filing Date
2024-03-14
Accepted
2024-03-14 16:16:50
Documents
20
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A krtx-20231231.htm   iXBRL 10-K/A 1606186
2 EX-31.3 krtx-ex31_3.htm EX-31.3 5297
3 EX-31.4 krtx-ex31_4.htm EX-31.4 5290
4 GRAPHIC img89312032_0.jpg GRAPHIC 436481
5 GRAPHIC img89312032_1.jpg GRAPHIC 203420
6 GRAPHIC img89312032_2.jpg GRAPHIC 226439
7 GRAPHIC img89312032_3.jpg GRAPHIC 701
8 GRAPHIC img89312032_4.jpg GRAPHIC 22886
  Complete submission text file 0000950170-24-031505.txt   6538329

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT krtx-20231231.xsd EX-101.SCH 1635692
22 EXTRACTED XBRL INSTANCE DOCUMENT krtx-20231231_htm.xml XML 18043
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38958 | Film No.: 24750379
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)